Atea Pharmaceuticals, Inc.
Industry: Life Sciences ・ $AVIR on Nasdaq
Insider Purchase
+$82,000
+5.53%
Shares
Shares Volume: 25,000 Shares
Average Share Price: $3.28
INSIDER
BERGER FRANKLIN M
Director
reported on Jan 17 2025
traded on Jan 15 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 476,897 |
| PURCHASES/SALES 1Y | 2 / 1 |
| P/S VALUE RATIO | 0.16 |
| AVERAGE PURCHASE VALUE | $82,000 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 0 |
| PURCHASES/SALES 1Y | 2 / 10 |
| P/S VALUE RATIO | 0.091 |
| AVERAGE PURCHASE VALUE | $82,000 |
| COMPANY PREVIOUS TRADES |